PVC medicinal sheet — the rigid film used for pharmaceutical blister packs — is made mainly from polyvinyl chloride resin with a small amount of processing aid, produced by extrusion or calendering. It is a packaging material built to medicinal requirements: each tablet, pill or capsule is separated into its own cavity, which makes the blister the smallest unit of packaging and improves both the accuracy and the safety of dispensing.
The processing route is simple, the investment is small and the material forms easily. That is why pharmaceutical plants moved to this packaging in the early 1990s and have stayed with it, and why it cut both production cost and lead time at the same time.
In China, PVC medicinal sheet accounts for more than 95% of PTP (press-through-pack) material. Abroad the picture is more mixed: PVC is still the main material for aluminium-PVC blister packaging at roughly 60%, with PP, PET and PS taking part of the remainder. Those alternatives have not closed the performance gap, and the appearance of the pack has not changed either. Composite packaging is the fastest-growing segment — its growth rate runs three to four times that of single-material packaging.
The compound is roughly 90% PVC resin. A typical medicinal sheet runs 88–92% PVC resin, about 1.5% stabilizer, 4.5% reinforcing agent, 1–1.5% processing aid, 0–1% plasticizer and 1.5–2% lubricant. Raw material selection has to satisfy two things at once: processability on the PTP line, and hygiene in pharmaceutical production.
We supply rigid PVC sheet for pharmaceutical packaging from 0.1 mm to 0.5 mm, in widths of 30–100 cm and rolls of 20–500 m, packed with plastic film and kraft paper. Other thicknesses are made to order.
